Table 1.
Baseline characteristics of the total population (n = 224)
| Patients | |
| Age (years) | 58 (51, 67) |
| Male | 185 (82.6%) |
| Previous disorder: | |
| Myocardial infarction | 16 (7.1%) |
| Angina pectoris | 7 (3.1%) |
| Hypertension (treated) | 58 (25.9%) |
| Hyperlipidaemia (treated) | 20 (8.9%) |
| Status at baseline | |
| Current smoker | 109 (48.7%) |
| BMI (kg/m2) | 26 (24.4, 28.7) |
| Waist circumference (cm) | 100 (94, 107) |
| Stent in culprit lesion | 215 (96.0%) |
| Gp IIb/IIIa antagonist treated | 79 (35.3%) |
| Single -coronary vessel disease | 139 (62.1%) |
| Double-coronary vessel disease | 64 (28.6%) |
| Triple-coronary vessel disease | 21 (9.4%) |
| Time from symptoms to balloon (min) | 219 (140, 378) |
| Time from PCI to OGTT (min) | 995 (689, 1277) |
| Medication at discharge from CCU | |
| Aspirin | 224 (100%) |
| Clopidogrel | 222 (99.1%) |
| β-blockers | 181 (80.8%) |
| Lipid lowering agents | 221 (98.7%) |
| Angiotensin converting enzyme-inhibitors | 36 (16.1%) |
| Angiotensin II-receptor blockers | 18 (8.0%) |
| LVEFa | 64 (56, 70) |
Data are presented as median with inter-quartile range or proportions.
BMI: body mass index, LVEF: left ventricular ejection fraction. aLVEF diagnosed 3 months after discharge.